News from NORD

NORD Board Chair to Moderate Social Security Administration Forum


 

NORD Board Chair Marshall Summar, MD, will moderate a Social Security Administration (SSA) National Disability Forum on Compassionate Allowances and Rare Diseases on Nov. 7, 2017. Speakers will discuss the challenges of living with rare diseases and will recommend specific diseases for SSA’s Compassionate Allowances list.

The Compassionate Allowances list is a list of diseases or medical conditions that almost invariably meet SSA guidelines for disability assistance. Applications from individuals with those diagnoses qualify for expedited review.

Medical professionals and patient representatives are invited to participate in this event. Registration to attend the Washington, DC forum in person or to listen to the forum via teleconference may be done online.

SSA will also be accepting questions or comments about Compassionate Allowances on Twitter during the forum. Use the hashtag #SSANDForum and/or direct comments to @SSAOutreach. Questions or comments may also be sent by email to nationaldisabilityforum@ssa.gov.

For two weeks after the event, SSA will be accepting suggestions online regarding diseases or conditions to be considered for the list. Read about the Compassionate Allowances Initiative and view the current list of conditions here.

Recommended Reading

Global CMTC/OVM Conference to Take Place in The Netherlands
Clinician Reviews
Conan O’Brien to Host Congenital Hyperinsulinism International Event
Clinician Reviews
CurePSP International Research Symposium to Take Place in San Francisco
Clinician Reviews
Foundation Fighting Blindness Opens USH2A Natural History Study
Clinician Reviews
PSC Partners Seeking a Cure Surpasses 1,000 Patients in International Registry … and Makes an Unexpected Finding Regarding Misdiagnosis
Clinician Reviews
TESS Research Foundation Announces Grant Recipients
Clinician Reviews
Vestibular Disorders Association Celebrates Balance Awareness Week
Clinician Reviews
Nominate a Colleague or Patient for a NORD Rare Impact Award
Clinician Reviews
Orphan Drugs Are Not Driving Up the Cost of Health Care, According to New Study
Clinician Reviews
NORD Call for Abstracts Reopened
Clinician Reviews